Gene | Fold ADSC mono-/co-culture | Up-/down-regulation | Main impact of gene product |
---|---|---|---|
Part 1. Changes in the gene expression of ADSCs | |||
E-Cadherin | n.d. | → | EMT, i, m, ms |
N-Cadherin | 1.0 (0.0) | → | EMT |
CCL2 | 9.4 (5.0) | ↑ | a, i, m, ms, p, EMT |
CCL7 | 11 (3.8) | ↑ | a, i, m, ms, p |
CCL8 | 42 (15) | ↑ | a, i, m, p |
CCL13 | 8.0 (0.0) | ↑ | a, i, m, p |
CCL20 | 32 (23) | ↑ | im |
CSF-2 | 38 (20) | ↑ | a, i, m |
CSF-3 | 258 (2.3) | ↑ | im |
CXCL1 | 54 (16) | ↑ | a, i, m, ms, p |
CXCL2 | 16 (0.0) | ↑ | a, i, m |
CXCL3 | 27 (7.8) | ↑ | a, i, m |
CXCL5 | 9.4 (5.0) | ↑ | a, i, m |
CXCL6 | 129 (0.2) | ↑ | a, i, m, ms, p |
CXCL11 | 4.0 (0.0) | ↑ | a, i, m |
CXCL12 | 12 (5.7) | ↑ | a, i, m |
IL-1α | 12 (5,6) | ↑ | a, ms |
IL-1β | 119 (100) | ↑ | a, ms |
IL-6 | 88 (84) | ↑ | p |
IL-8 | 29 (25) | ↑ | a |
LYPD3 | 6.1 (2.9) | ↑ | i, ms |
MMP-3 | 108 (32) | ↑ | m, i, ms |
NR4A3 | 4.7 (2.8) | ↑ | p |
PTGS2 | 74 (39) | ↑ | a, i, im, m, ms, p |
TLR-2 | 4.6 (2.5) | ↑ | a, m, i |
WISP-1 | 6.1 (2.9) | ↑ | m, im |
Gene | Fold A431-SCC mono-/co-culture | Up-/down-regulation | Main impact of gene or gene product |
Part 2. Changes in the gene expression of A431-SCCs | |||
E-Cadherin | * | ↓↓ | EMT, i, m, ms |
N-Cadherin | 98 (2.3) | ↑ | EMT |
CXCL9 | 4.4 (0.2) | ↓ | a |
CXCL10 | 4.8 (0.1) | ↓ | a |
CTKS | 4.1 (2.9) | ↑ | m, i, ms |
FN1 | 2.5 (1.3) | ↑ | m, i |
HGF | 20 (12) | ↑ | a, m, i, |
ITGB3 | 10 (5.1) | ↑ | m, i, ms |
MMP-1 | 9.4 (5.1) | ↑ | m, i, ms |
MMP-2 | 3.1 (1.5) | ↑ | m, i, ms |
MMP-3 | 191 (89) | ↑ | m, i, ms |
MMP-7 | 4.8 (2.4) | ↑ | m, i, ms |
MMP-9 | 3.4 (0.2) | ↓ | m, i, ms |
PTGS2 | 2.7 (0.8) | ↑ | a, i, im, m, ms, p |
TWIST-1 | 11 (3.8 ) | ↑ | ms |